Nonetheless, in most cases, acquired resistance against TKIs occurs after an average of one year, leading to renewed tumor growth and progression, suggesting specific pathogenetic mechanisms, e.g., c-Met amplification [3,4,5]. Here, MET is linked to neoplasm.